| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/21/2010 | CN101780071A Application of osthole in preparation of medicament for preventing and treating myocardial fibrosis |
| 07/21/2010 | CN101780059A Transdermal preparation containing ligustrazine phosphate and preparation method thereof |
| 07/21/2010 | CN101780056A Self-assembling proliposome soft capsule and preparation method thereof |
| 07/21/2010 | CN101780037A Dipyridamole self-emulsifying medicament administration system and preparation method thereof |
| 07/21/2010 | CN101780036A Butyrate clevidipine lipid microsphere injection and preparation method thereof |
| 07/21/2010 | CN101780030A Ginkgo flavone aglycone solid dispersion and preparation method thereof |
| 07/21/2010 | CN101779885A Traditional Chinese medicine health care pillow and pillowcase and medicine bag for guarding heart and promoting restoration consciousness |
| 07/21/2010 | CN101779883A Chinese medicine healthcare pillow for soothing liver and checking exuberance of yang, pillowcase and medicine bag |
| 07/21/2010 | CN101362725B Method for preparing tetramethylpyrazine guanidine derivatives and application thereof |
| 07/21/2010 | CN101229376B Medicine compounds containing isosorbide mononitrate for treating high blood pressure |
| 07/21/2010 | CN101229344B Chinese traditional medicine composite for treating heart disease and preparing method thereof |
| 07/21/2010 | CN101224187B Dual functional polymer nanometer glue bunch and preparing method and application in preparing medicine for treating second narrow blood vessel |
| 07/21/2010 | CN101181600B Traditional Chinese medicine composition for curing cardiovascular and cerebrovascular diseases |
| 07/21/2010 | CN101167717B Novel isosorbide mononitrate injection |
| 07/21/2010 | CN101143851B Ligustrazine aromatic acid ether derivatives, preparation method thereof, medicament composition and use |
| 07/21/2010 | CN101138545B Clathrate compound containing ginsenoside Rg2 and method of preparing the same |
| 07/21/2010 | CN101040877B Medicine function of Boshi brachytheciaceae |
| 07/21/2010 | CN101032534B Method of preparing Ilex rotunda Thunb total saponins and the application thereof |
| 07/20/2010 | US7759486 2,4,5-Trisubstituted pyrimidine compounds |
| 07/20/2010 | US7759399 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance |
| 07/20/2010 | US7759392 4-nitroxybutyric acid ester derivatives of drugs such as acetaminophen, having an improved therapeutic index (efficacy/toxicity ratio) or a lower risk/benefit ratio, usedfor treating oxidative stress and endothelian dysfunctions, inflammation and pain |
| 07/20/2010 | US7759388 Phenylalanine derivatives |
| 07/20/2010 | US7759384 Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment |
| 07/20/2010 | US7759380 Substituted pyrrolines as kinase inhibitors |
| 07/20/2010 | US7759373 nitrogen-containing 5-membered heterocyclic compound |
| 07/20/2010 | US7759367 Pharmaceutical compositions and their uses |
| 07/20/2010 | US7759353 Substituted spiro iminopyrimidinones as aspartyl protease inhibitors, compositions, and methods of treatment |
| 07/20/2010 | US7759343 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 07/20/2010 | US7759336 chemokine receptor antagonists such as N-(4-azepan-1-ylpyrimidin-2-yl)ethane-1,2-diamine, used for the treatment and prevention of inflammatory diseases, allergic diseases, acquired immunodeficiency syndrome infection with human immunodeficiency virus |
| 07/20/2010 | US7759333 pentaazacycle manganese complexes, as mimetics for oxidoreductase enzymes,used for the treatment of age-related macular degeneration, diabetic retinopathy and edema; vision defects |
| 07/20/2010 | US7759326 Modulate sphingosine-1-phosphate (S1P) receptors with fewer side effects; for example, 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentylphosphonic acid monoester; prophylactic or therapeutic agents against rejection of organ transplants, skin grafts, rheumatoid arthritis, lupus |
| 07/20/2010 | US7759323 Highly purified antiendotoxin compound |
| 07/20/2010 | US7759091 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor |
| 07/20/2010 | CA2547234C The use of quaternary pyridinium salts as vasoprotective agents |
| 07/20/2010 | CA2448798C Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 07/20/2010 | CA2447865C Novel sulfonic acid derivatives |
| 07/20/2010 | CA2446942C Use of il-18 inhibitors for the treatment or prevention of sepsis |
| 07/20/2010 | CA2406077C Formulation for the prevention of cardiovascular disease |
| 07/20/2010 | CA2399001C Integrin expression inhibitor |
| 07/20/2010 | CA2322487C Novel prodrugs for phosphorus-containing compounds |
| 07/20/2010 | CA2197235C Adenovirus comprising a gene coding for glutathion peroxidase |
| 07/15/2010 | WO2010079668A1 Olefin compound |
| 07/15/2010 | WO2010079431A2 Compounds for the prevention and treatment of cardiovascular disease |
| 07/15/2010 | WO2010079161A1 A b cell depleting agent for the treatment of atherosclerosis |
| 07/15/2010 | WO2010079156A1 Non-invasive tools for detecting vulnerable atherosclerotic plaques |
| 07/15/2010 | WO2010079120A1 Benzimidazole and pyrazolopyridine derivatives for treating and/or preventing cardiovascular diseases |
| 07/15/2010 | WO2010078865A1 Nω-HYDROXY-L-ARGININE DERIVATIVES FOR THE TREATMENT OF DISEASES |
| 07/15/2010 | WO2010078730A1 Preparation of ginsenoside-rd propylene glycol aqueous solution and new use thereof in anti-inflammation, immunosuppression and anti organ-graft rejection |
| 07/15/2010 | WO2010078624A1 Materials and methods for the treatment of hypertension |
| 07/15/2010 | WO2010059602A3 Inhibitors of diacylglycerol acyltransferase |
| 07/15/2010 | WO2010047999A3 Method for treating pulmonary arterial hypertension |
| 07/15/2010 | WO2010045755A8 Glycosyl-derivatives of puerarin, pharmaceutical compositon, preparation method and use thereof |
| 07/15/2010 | WO2009105624A3 Simultaneous delivery of receptors and/or co-receptors for growth factor stability and activity |
| 07/15/2010 | US20100179304 Somatostatin-Dopamine Chimeric analogs |
| 07/15/2010 | US20100179225 POI Prevention |
| 07/15/2010 | US20100179224 Acyclic Sulfamide Derivatives |
| 07/15/2010 | US20100179212 Pharmaceutical composition which improves in vivo gene transfer |
| 07/15/2010 | US20100179203 Novel pyrazole derivatives useful as potassium channel modulators |
| 07/15/2010 | US20100179201 Novel thiazole-based compound and inhibitor of t-type calcium channel containing the same |
| 07/15/2010 | US20100179191 Glucopyranosyl-substituted cyclopropylbenzene derivatives, pharmaceutical compositions containing such compounds, their use as sglt inhibitors and process for their manufacture |
| 07/15/2010 | US20100179189 Pyrroline derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 07/15/2010 | US20100179182 Pharmaceutical formulation |
| 07/15/2010 | US20100179168 Aryl and heteroaryl sulphonamides as growth hormone secretagogue receptor agonists |
| 07/15/2010 | US20100179167 Methods of using substituted isoxazolo pyridinones as dissociated glucocorticoids |
| 07/15/2010 | US20100179158 Inhibitors of cyclic amp phosphodiesterases |
| 07/15/2010 | US20100179157 Therapeutic agent for cerebral infarction |
| 07/15/2010 | US20100179143 Naphthyridine, derivatives as p13 kinase inhibitors |
| 07/15/2010 | US20100179140 Indenoisoquinolinone analogs and methods of use thereof |
| 07/15/2010 | US20100179139 Pyrrolopyridine compounds, process for their preparation, and their use as medicaments |
| 07/15/2010 | US20100179137 Pyridone compound |
| 07/15/2010 | US20100179136 N-amino tetrahydrothiazine derivatives, method of manufacture and use |
| 07/15/2010 | US20100179128 Xanthine derivatives as selective hm74a agonists |
| 07/15/2010 | US20100179124 Thieno-pyridine derivatives as mek inhibitors |
| 07/15/2010 | US20100179119 Inhibitors of Integrin Alpha2Beta1 Based on Prolyl Diaminopropionic Acid Scaffold |
| 07/15/2010 | US20100179109 Renin inhibitors |
| 07/15/2010 | US20100179103 Curcumin cyclodextrin combination for preventing or treating various diseases |
| 07/15/2010 | US20100179102 Injectable cross-linked polymeric preparations and uses thereof |
| 07/15/2010 | US20100179097 Use of kauranes compounds in the manufacture of medicament |
| 07/15/2010 | US20100178365 Epicatechin deficient green tea |
| 07/15/2010 | US20100178341 BILAYERED TABLET COMPRISING NIACIN AND HMG-CoA REDUCTASE INHIBITOR |
| 07/15/2010 | US20100178337 Composition comprising an active agent with low aqueous solubility |
| 07/15/2010 | US20100178334 Oral Pharmaceutical Dosage Form Comprising as Active Ingredients a Proton Pump Inhibitor together with Acetyl Salicyclic Acid |
| 07/15/2010 | US20100178287 Use of coagulation proteins to lyse clots |
| 07/15/2010 | US20100178283 Hypoxia related genes and proteins for the treatment and diagnosis of pregnancy related complications |
| 07/15/2010 | US20100178280 Use of sirt7 for treating age-related diseases |
| 07/15/2010 | US20100178269 Compositions and Methods for the Treatment of Heart Failure |
| 07/15/2010 | US20100178243 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system |
| 07/15/2010 | DE102009004245A1 Neue anellierte, Heteroatom-verbrückte Pyrazol- und Imidazol-Derivate und ihre Verwendung Last fused, heteroatom-bridged pyrazole and imidazole derivatives and their use |
| 07/15/2010 | CA2838846A1 Methods for treating vascular leak syndrome |
| 07/15/2010 | CA2749047A1 Non-invasive tools for detecting vulnerable atherosclerotic plaques |
| 07/15/2010 | CA2747417A1 Compounds for the prevention and treatment of cardiovascular disease |
| 07/15/2010 | CA2744670A1 A b cell depleting agent for the treatment of atherosclerosis |
| 07/14/2010 | EP2206772A2 Method of collecting placental stem cells |
| 07/14/2010 | EP2206726A1 Non-invasive tools for detecting vulnerable atherosclerotic plaques |
| 07/14/2010 | EP2206720A1 Albumin fusion proteins |
| 07/14/2010 | EP2206702A1 Bicyclic compound, production and use thereof |
| 07/14/2010 | EP2206534A1 Dibenzocycloheptanone derivatives und pharmaceutical agents containing these compounds |
| 07/14/2010 | EP2206511A1 Protein a compositions and methods of use |
| 07/14/2010 | EP2205616A1 Novel sulfated oligosaccharide derivatives |
| 07/14/2010 | EP2205604A1 {[5-(phenyl)-6-phenylpyrrolo[2,1-f][2,1,4]triazin-4-yl]amino}carboxylic acid derivatives and related compounds as prostacyclin (pgi2) ip receptor activators for treating cardiovascular disorders |